Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Stage IIS Clinical Trial Evaluating Hemi-Ablative Low Dose Rate (LDR) Brachytherapy for Localised Prostate Cancer

NCT02632669 is registered in ClinicalTrials.gov with Royal Surrey County Hospital NHS Foundation Trust as lead sponsor.

NCT NCT02632669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02632669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Stage IIS Clinical Trial Evaluating Hemi-Ablative Low Dose Rate (LDR) Brachytherapy for Localised Prostate Cancer
Lead sponsor
Royal Surrey County Hospital NHS Foundation Trust
Phase
Not applicable
Overall status
Completed
Start date
July 6, 2012
Completion date
August 31, 2018
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the prostate, prostatic neoplasms